92 related articles for article (PubMed ID: 18430101)
1. Prognostic role of immunosuppressive acidic protein in patients with esophageal cancer.
Kogure M; Kashimura S; Matsuyama S; Ohtani S; Saze Z; Odashima Y; Saitoh T; Soeta N; Osuka F; Hoshino Y; Saito T; Terashima S; Terashima M; Gotoh M
Dis Esophagus; 2008; 21(3):214-9. PubMed ID: 18430101
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Miyazawa Y; Shihratori T; Hayashi H; Aoki T; Sugaya M; Gunji Y; Kobayashi S; Ochiai T
Dis Esophagus; 2003; 16(2):102-6. PubMed ID: 12823207
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
[TBL] [Abstract][Full Text] [Related]
4. Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers.
Oka M; Mitsunaga H; Hazama S; Yoshino S; Suzuki T
Surg Today; 1993; 23(8):669-74. PubMed ID: 8400669
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Sakamoto J; Teramukai S; Koike A; Saji S; Ohashi Y; Nakazato H
Cancer; 1996 Jun; 77(11):2206-12. PubMed ID: 8635085
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.
Sakamoto J; Koike A; Saji S; Teramukai S; Ohashi Y; Nakazato H
Surg Today; 1992; 22(6):530-6. PubMed ID: 1472793
[TBL] [Abstract][Full Text] [Related]
7. Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma.
Igarashi T; Tobe T; Kuramochi H; Akakura K; Ichikawa T; Hamano S; Suzuki N; Furuya Y; Ito H
Jpn J Clin Oncol; 2001 Jan; 31(1):13-7. PubMed ID: 11256835
[TBL] [Abstract][Full Text] [Related]
8. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
10. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
11. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Association between host or tumor factors and survival.
Munemoto Y; Iida Y; Abe J; Saito H; Fujisawa K; Kasahara Y; Mitsui T; Asada Y; Miura S
Int J Oncol; 2002 Feb; 20(2):403-11. PubMed ID: 11788909
[TBL] [Abstract][Full Text] [Related]
12. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
[TBL] [Abstract][Full Text] [Related]
13. Serum immunosuppressive acidic protein as an interleukin-6 related index of deteriorating condition in gastric cancer patients.
Ikuta S; Miki C; Tanaka K; Konishi N; Mohri Y; Tonouchi H; Kusunoki M
Dig Surg; 2003; 20(6):532-8. PubMed ID: 14534376
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
[TBL] [Abstract][Full Text] [Related]
15. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of immunosuppressive acidic protein (IAP) in human esophageal squamous cell carcinoma].
Guo SZ; Shen Q; Zhang HB
Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):125-7. PubMed ID: 7924862
[TBL] [Abstract][Full Text] [Related]
17. [Study of PyNPase activity in patients with gastric cancer--the association with preoperative IAP values].
Kirita T; Hamano K; Mabuchi G; Seshimo A; Kawase A; Miyashita M; Inada N
Gan To Kagaku Ryoho; 1995 Mar; 22(4):509-14. PubMed ID: 7887642
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
Battaglia F; Scambia G; Panici PB; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
[TBL] [Abstract][Full Text] [Related]
19. [Urine levels of immunosuppressive acidic protein in patients with or without cancer].
Hirayama T
Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1379-87. PubMed ID: 4079895
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive substance in the sera of head and neck cancer patients.
Yamanaka N; Harabuchi Y; Himi T; Kataura A
Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
